Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

NCT03548415 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Acromegaly

Interventions

DRUG: IONIS-GHR-LRx
DRUG: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.